Brace for BREXIT
Post-Brexit, a strategic realignment can help India emerge as a significant partner for pharmaceuticals in the both the EU and the…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Cover Story
Revolution in Pharma Labelling
DGFT’s track and trace initiative has spurred solution providers to come up with innovative labelling options to cope with…
‘We now see the opportunity to further develop our drug delivery business in India’
Karen Flynn, Senior Vice President and Chief Commercial Officer, West Pharmaceutical Services, in an interaction with Sachin…
‘We support the Prime Minister’s Make in India call’
Datwyler is planning a FirstLine plant in Satara, Maharashtra, the company's first facility outside Europe. Rahul Dev, Vice…
‘Packaging innovation has a large role to play in the highly regulated pharma market’
AVPS Chakravarthi, Managing Director, Ecobliss recently delivered a session on innovations in pharmaceutical packaging at WPO…
‘We conduct exclusive industry need-based programmes’
SIES-SOP’s endeavour is to groom professionals dedicated to the cause of developing packaging that is functionally efficient with…
‘Packaging audit is a unique service rendered by PCR’
In a span of less than four years, Packaging Clinic and Research Institute (PCRI) has marked its presence in the Indian pharma…
Intelsius launches Plantol PCM
It will be beneficial for the transport of whole blood products
Almost all major manufacturers of pharma products in India have acknowledged and responded to the…
Javin Bhinde, Managing and Chief Executive Officer, SynCore Consulting shares details of the PatientSafe India conference this…
A Clash of IPR Cultures
India’s recently released national IPR policy has spurred fresh sparring between various lobbies. As international pressure to…
IPR in the Indo-US pharma trade relationship
India has retained her place on the Priority Watch List of the US TR's Super 301 report. With the Cabinet approving the National…
M&As ka Side Effects
Indian pharma companies have notched up some aggressive global buys recently but the sector's experience with cross border…
Going Green
Though the government is encouraging pharma companies to explore less accessed zones across India, it also expects companies to…
Are We Grappling Skewed Perceptions of GMP?
Indian Pharma Inc's waking up to the importance of GMP compliance and it has become a top priority in board room meetings but…
‘The companies who export must comply with the regulations of the importing country’
Sudhanshu Pandey, Joint Secretary, Department of Commerce, Ministry of Commerce & Industry, Government of India takes some…
Pharma quality assurance in 21st century: Sharper focus needed on education, training and…
Ajaz S Hussain, Founder CEO, Insight Advice & Solutions, and President, The National Institute for Pharmaceutical Technology…
Building quality excellence in pharma industry
With the pharma industry expanding scale and complexity, quality has emerged as a major focus area. Is quality merely a risk to be…
Pharma quality and compliance: Has the ‘elephant in the boardroom’ been recognised?
SM Mudda, Chairman, Regulatory Affairs Committee, IDMA, Mumbai examines where India’s pharma industry stands in terms of current…
Indian pharma: Bad at GMP compliance or victim of unwarranted regulatory expectations?
Viranchi Shah, Vice Chairman, Indian Drug Manufacturers’ Association (IDMA), opines that India's role in global healthcare cannot…
Tackling GMP non-compliance: A top priority!
Suresh Pareek,Managing Director, Ideal Cures emphasises the importance of eliminating GMP non-compliance and points out that its…